Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis.
about
Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohortSafety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study.Low level of physical activity in women with rheumatoid arthritis is associated with cardiovascular risk factors but not with body fat mass--a cross sectional study.Beneficial effects of Hibiscus rosa-sinensis L. flower aqueous extract in pregnant rats with diabetes.Total cholesterol and LDL levels decrease before rheumatoid arthritis.Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatmentIdentification of risk factors for elevated transaminases in methotrexate users through an electronic health record.The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects.Cardiovascular risk management in patients with inflammatory arthritis: what is good for the joint is good for the heart and vice versa!The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal studyMathematical modeling of corticosteroid pharmacogenomics in rat muscle following acute and chronic methylprednisolone dosingEffect of Erythrina variegata seed extract on hyperlipidemia elicited by high-fat diet in wistar ratsIncreased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study.Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular diseaseAtherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled studyGlucocorticoids in the treatment of early and late RADisease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis.Hyperlipidemia in rheumatoid arthritis patients in Saudi Arabia. Correlation with C-reactive protein levels and disease activity.A long-term, observational cohort study on the safety of low-dose glucocorticoids in ankylosing spondylitis: adverse events and effects on bone mineral density, blood lipid and glucose levels and body mass indexEarly functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register.Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid ArthritisAccelerated atherosclerosis in inflammatory rheumatic diseases.Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis.What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapyCardiovascular disease and rheumatoid arthritis: an update.High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study.Cardiovascular involvement in rheumatoid arthritis.Metabolic syndrome in rheumatoid arthritisThe heart and cardiovascular manifestations in rheumatoid arthritis.Atherogenic lipid profiles and its management in patients with rheumatoid arthritis.Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial.Is the frequency of metabolic syndrome higher in South Korean women with rheumatoid arthritis than in healthy subjects?Rheumatoid arthritis and cardiovascular disease: an update on treatment issues.Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.
P2860
Q30839061-610D5AAC-35CD-4BD7-9389-0BF6E24EDFC9Q31000488-F66D3399-1DB0-43C3-BBD7-F31EC67C9C46Q33691624-FCC38243-A0D3-4BEB-95C7-0AC8EC9A9A1DQ33793453-C8E6CB9F-0CEC-4AA9-BF39-EEE3D62E6E32Q33828860-464FBE85-219B-4A8B-AE0C-303BDBA49F3CQ33931317-C0489149-2A40-4F33-A69D-2CD20578C4EAQ33943374-AE1B9064-C272-49F7-A70A-C0EE553B8705Q33955217-FC2A0D69-5362-480C-BA71-1009C930902DQ34114349-3FA9F4F3-137D-4C6E-B81E-1486FB0DA68EQ34167653-80B195D0-F2EF-42DB-A35B-C20EA270E7D3Q34272487-D2BAEC1B-2D8A-4B4D-B506-73CE3B079857Q34335463-61D42352-2E40-4152-A1FD-932BB3085016Q34373858-14A8802A-6D97-4011-BAD9-2BE470718D41Q34614038-8E295482-216E-4548-B982-6053272D0B6DQ34684331-0A0FE973-7298-4719-A4D3-152D4C2B8903Q34897630-B2338038-D06F-4C4B-B03D-40E789292A30Q35552156-106738A8-228B-43D1-AC91-B5FC5D01B5F4Q35605663-B73AD196-DC62-499F-977A-14017F1207D6Q35617716-E2B18C30-9C02-4690-9A74-26DE94ADE6CBQ35638659-FAD79514-178B-4681-A610-E3305325F9F9Q35681167-E0615C93-7E1B-4436-884D-E39F06DA3F38Q35691844-E1F95707-1150-43F6-8324-BA33559BDE0DQ35760080-9BD6DCCD-4C02-4BA9-96E4-61025025E295Q35891702-BB0FC41A-0722-4858-81B7-60F69A891EB2Q35932689-8BB2121A-31C4-4A3E-ACF8-9748E40B2602Q35954510-63F67CDB-9381-4C1B-9B4A-B26CA483CC79Q35954625-989C87F9-85E4-49C5-B4DF-D41C69BF865CQ36005129-78F56315-0E07-4794-9E8B-3060394C96AAQ36113215-D0A668FD-9BA5-4B0F-88CE-604F3D404B88Q36218375-B5354342-516B-4EAA-A044-43C375D846C4Q36245981-2D52FAB6-D124-4B5B-8A81-3A9A57812B8FQ36283434-D57B171E-E0B8-4B71-A3B0-4FA7B4C56787Q36568868-FA548C83-805D-48A2-BAF6-2C39D7255593Q36596365-4AB178A1-6B48-477D-B283-790B76CEB47DQ36596894-FDC61738-C6B4-449D-BEB6-54976F95384FQ36640598-24FFF259-9171-42B9-B1A5-7DC527E23FAAQ36705720-96B0741F-D763-4EAE-B253-A89EC662E47AQ36812587-1D6DCB81-7016-403E-90E3-F04113E6F03DQ36901936-A4054106-8A5B-4B98-8E33-75C524D23629Q37058791-072A9597-7744-4ECE-AFB9-B0A6FB2BED27
P2860
Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Influence of glucocorticoids a ...... nts with rheumatoid arthritis.
@ast
Influence of glucocorticoids a ...... nts with rheumatoid arthritis.
@en
type
label
Influence of glucocorticoids a ...... nts with rheumatoid arthritis.
@ast
Influence of glucocorticoids a ...... nts with rheumatoid arthritis.
@en
prefLabel
Influence of glucocorticoids a ...... nts with rheumatoid arthritis.
@ast
Influence of glucocorticoids a ...... nts with rheumatoid arthritis.
@en
P2093
P2860
P356
P1476
Influence of glucocorticoids a ...... nts with rheumatoid arthritis.
@en
P2093
A C Verhoeven
A E Voskuyl
B A C Dijkmans
C J A Doelman
M T Nurmohamed
R J van de Stadt
Sj van der Linden
T W J Huizinga
P2860
P304
P356
10.1136/ARD.62.9.842
P407
P577
2003-09-01T00:00:00Z